Implement AI faster without losing compliance
AI is reshaping digital operations across life sciences. Yet deploying AI within a GxP-regulated environment brings distinct risks, particularly when data is distributed across disparate systems and workflows.
Without solid foundations, organizations encounter hurdles such as fragmented data, gaps in audit trails, and limited traceability. Model transparency and explainability are also drawing increased regulatory attention during inspections. Moreover, because AI models continuously evolve, a structured lifecycle management strategy, aligned with CSA principles, is indispensable.
This session covers the same core presentation as Session 1, but with a different focus: your questions take center stage. Rather than a one-way walkthrough, this is an open, interactive session built around debate, discussion, and answering the questions already raised in Session 1, as well as new ones from the live audience. If you attended the first session and left with unanswered questions, or if you're joining for the first time and want a more conversational format, this is the session for you.
QbD Group and delaware present how their combined strengths deliver a pragmatic, integrated, and validated approach to AI adoption in regulated life sciences settings, helping you transition from proof-of-concept to compliant deployment with confidence.